Robert I. Goldfarb - Jul 27, 2022 Form 4 Insider Report for NEXIEN BIOPHARMA, INC. (NXEN)

Role
Chief Operating Officer
Signature
Robert I. Goldfarb
Stock symbol
NXEN
Transactions as of
Jul 27, 2022
Transactions value $
$0
Form type
4
Date filed
9/14/2022, 05:45 PM
Next filing
Oct 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXEN Common Stock Award +250K +24.3% 1.28M Jul 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXEN Options to purchase common stock (right to buy) Award +1M 1M Aug 19, 2020 Common Stock 1M $0.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued in lieu of compensation for services.